Related Experiment Video
Updated: May 29, 2026
08:34
Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
Bilberries and their anthocyanins ameliorate experimental colitis
Heidi Piberger1, Anett Oehme, Claudia Hofmann
1Department of Internal Medicine I, University of Regensburg, Regensburg, Germany.
Molecular Nutrition & Food Research
|September 30, 2011
Summary
Dried bilberries and their anthocyanins show promise in treating inflammatory bowel disease (IBD). These compounds reduced inflammation and apoptosis in experimental colitis, suggesting potential therapeutic benefits for IBD patients.
Area of Science:
- Gastroenterology
- Pharmacology
- Nutritional Science
Background:
- Inflammatory bowel disease (IBD) encompasses chronic gastrointestinal inflammatory conditions.
- Bilberries are rich in anthocyanins (ACs), known for antioxidant and anti-inflammatory properties.
- Patients with IBD report symptom improvement with bilberry consumption.
Purpose of the Study:
- To investigate the therapeutic potential of dried bilberries and anthocyanins (ACs) in experimental colitis models.
- To assess the effects of bilberries and ACs on disease severity, cytokine secretion, and apoptosis in the colon.
Main Methods:
- Acute and chronic colitis were induced in mice using dextran sodium sulphate (DSS).
- Mice were treated with dried bilberries or purified ACs.
- Cytokine levels in mesenteric lymph nodes (MLNs) and apoptosis in colonic tissue were analyzed.
Main Results:
- Bilberry and AC administration ameliorated DSS-induced colitis severity in both acute and chronic models.
- Treatment reduced pro-inflammatory cytokine secretion (IFN-γ, TNF) from MLN cells.
- Bilberries and ACs inhibited inflammation-induced apoptosis in colonic epithelial cells.
Conclusions:
- Dried bilberries and their anthocyanins demonstrate significant therapeutic effects in experimental colitis.
- These findings support the potential of bilberries and ACs as natural agents for managing IBD.
- Clinical studies are warranted to confirm the efficacy of bilberries and ACs in human IBD patients.
More Related Videos
Related Concept Videos
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...